Overview
- Holtec said it has suspended its planned U.S. initial public offering and will keep evaluating the timing but gave no new schedule for the deal.
- The company had proposed selling roughly 50 million Class A shares to raise up to $900 million at a $15–$18 price range, with Nasdaq listed underwriters lined up.
- Holtec cited weak market conditions after several recent nuclear issuers traded well below their offer prices, including large declines at X-Energy and Standard Nuclear.
- The firm said its near-term operational focus remains on advancing its SMR-300 small modular reactor program and work to recommission the Palisades site, which the IPO proceeds were intended to support.
- The pause could delay additional funding for SMR licensing and U.S. manufacturing expansion and may affect the timing of Palisades work and related local economic plans as Holtec reviews market conditions.